INCREASED FC-RECEPTOR-MEDIATED CLEARANCE VIA RETICULOENDOTHELIAL SYSTEM IN PATIENTS WITH NEPHROTIC SYNDROME

被引:0
|
作者
MULLER, C
TRAINDL, O
SCHWARZ, M
KOVARIK, J
LEIBL, H
ZIELINSKI, CC
EIBL, MM
机构
[1] UNIV VIENNA,DEPT GASTROENTEROL & HEPATOL 2,A-1010 VIENNA,AUSTRIA
[2] UNIV VIENNA,DEPT MED 2,A-1010 VIENNA,AUSTRIA
[3] IMMUNO AG WIEN,VIENNA,AUSTRIA
[4] UNIV VIENNA,INST IMMUNOL,A-1010 VIENNA,AUSTRIA
来源
NEPHRON | 1991年 / 58卷 / 02期
关键词
RETICULOENDOTHELIAL SYSTEM; PHAGOCYTOSIS; FC-RECEPTOR-MEDIATED; NEPHROTIC SYNDROME;
D O I
10.1159/000186405
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Reticuloendothelial phagocytic cell function, which is an important participant in host defense, was investigated by studying the Fc-receptor-mediated clearance of IgG-anti-RhD-sensitized radiolabelled autologous erythrocytes in patients with nephrotic syndrome known to have an increased risk of infectious complications due to hypogammaglobulinemia. Patients with serum IgG concentrations < 500 mg/dl had a significantly accelerated Fc-receptor-mediated clearance (t1/2 = 52 +/- 3.6 min) compared to patients with IgG levels > 500 mg/dl (t1/2 = 93 +/- 17 min) or healthy controls (t1/2 = 100 +/- 7.5 min). Serum IgG concentrations correlated significantly with Fc-receptor-mediated clearance (t1/2: r = 0.70; p = 0.035) in patients with nephrotic syndrome. These results indicate that Fc-receptor-mediated clearance by the reticuloendothelial system is enhanced in patients with nephrotic syndrome with low serum IgG concentrations and may, at least in part, compensate for reduced opsonic antibody concentration.
引用
收藏
页码:150 / 154
页数:5
相关论文
共 50 条
  • [41] MODULATION OF HUMAN POLYMORPHONUCLEAR LEUKOCYTE IGG FC-RECEPTORS AND FC-RECEPTOR-MEDIATED FUNCTIONS BY IFN-GAMMA AND GLUCOCORTICOIDS
    PETRONI, KC
    SHEN, L
    GUYRE, PM
    JOURNAL OF IMMUNOLOGY, 1988, 140 (10): : 3467 - 3472
  • [42] Reduced Fc Receptor-Mediated Clearance as Explanation of Increased Antiplasmodial Antibody Levels in Cerebral Malaria Reply
    Dobano, Carlota
    JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (04): : 600 - 601
  • [43] Immunomodulatory activity of commonly used drugs on Fc-receptor-mediated human natural killer cell activation
    Theorell, Jakob
    Gustavsson, Anna-Lena
    Tesi, Bianca
    Sigmundsson, Kristmundur
    Ljunggren, Hans-Gustaf
    Lundbaeck, Thomas
    Bryceson, Yenan T.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (06) : 627 - 641
  • [44] Increased soluble leptin receptor in children with nephrotic syndrome
    Schroth, M
    Kratzsch, J
    Gröschl, M
    Rauh, M
    Rascher, W
    Dötsch, J
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11): : 5497 - 5501
  • [45] FC-RECEPTOR FUNCTION IN MINIMAL CHANGE NEPHROTIC SYNDROME OF CHILDHOOD
    DAVIN, JC
    FOIDART, JB
    MAHIEU, PR
    CLINICAL NEPHROLOGY, 1983, 20 (06) : 280 - 284
  • [46] Immunomodulatory activity of commonly used drugs on Fc-receptor-mediated human natural killer cell activation
    Jakob Theorell
    Anna-Lena Gustavsson
    Bianca Tesi
    Kristmundur Sigmundsson
    Hans-Gustaf Ljunggren
    Thomas Lundbäck
    Yenan T. Bryceson
    Cancer Immunology, Immunotherapy, 2014, 63 : 627 - 641
  • [47] RETICULOENDOTHELIAL SYSTEM (RES) FC RECEPTOR FUNCTION IN MULTIPLE-SCLEROSIS (MS)
    HEINICKE, HU
    COYLE, P
    HAMBURGER, M
    NEUROLOGY, 1981, 31 (04) : 146 - 146
  • [48] Increased arterial stiffness in patients with nephrotic syndrome
    Gungor, Ozkan
    Demirci, Meltem Sezis
    Kircelli, Fatih
    Tatar, Erhan
    Sipahi, Savas
    Hur, Ender
    Sen, Sait
    Toz, Huseyin
    Basci, Ali
    Ok, Ercan
    CLINICAL NEPHROLOGY, 2013, 79 (01) : 1 - 6
  • [49] RETICULOENDOTHELIAL SYSTEM FC-RECEPTOR FUNCTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    KABBASH, L
    BRANDWEIN, S
    ESDAILE, J
    DANOFF, D
    FUKS, A
    SHUSTER, J
    CLINICAL RESEARCH, 1982, 30 (02): : A653 - A653
  • [50] RETICULOENDOTHELIAL SYSTEM (RES) FC RECEPTOR FUNCTION IN RHEUMATOID-ARTHRITIS (RA)
    HAMBURGER, MI
    FIELDS, TR
    BENNETT, RS
    LAWLEY, TJ
    HALL, RP
    KARSH, JR
    KLIPPEL, J
    PLOTZ, PH
    FRANK, MM
    CLINICAL RESEARCH, 1981, 29 (01): : A158 - A158